Month: January 2022

Collaboration Aims to Further Connect Female Entrepreneurs with Necessary Capital to Succeed ST. LOUIS, Jan. 27, 2022 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced an alliance with LFE Capital, a growth equity firm dedicated to providing capital to women-owned and managed health and wellness businesses. As part of this partnership, Stifel is making a minority investment in LFE Capital and becoming an LP in its fourth fund. This investment is an important extension of Stifel’s initiative to develop relationships with the capacity to provide principal solutions. Founded in 2001 by Leslie Frecon, LFE Capital provides expansion or buyout capital to high-growth companies with revenues of $2-20 million. The firm’s strategy encompasses products and services that promote healthy living and improve healthcare with...

BANNOCKBURN, Ill., Jan. 27, 2022 (GLOBE NEWSWIRE) — Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2021 on Wednesday, February 23, 2022 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing (866) 360-3136 and referencing conference ID 7156207; or via a live audio webcast that will be available online at https://investors.optioncarehealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the...

WOODSIDE, Calif., Jan. 27, 2022 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth”), a leading provider of flexible capital solutions to late-stage and growth companies seeking an alternative to raising equity, today announced that it will release its financial results for the fourth quarter of 2021 and fiscal year ended 2021 after market close on Thursday, March 3, 2022. The Company will discuss its financial results on a conference call that day at 2:00 p.m. PT (5:00 p.m. ET). To participate in the conference call, please dial (844) 467-7753 and reference conference ID 3790578. A live webcast will be available in the investor section of the Company’s website at https://investors.runwaygrowth.com/, and will be archived for 90 days following the call. About Runway Growth Finance Corp. Runway Growth...

DENVER, Jan. 27, 2022 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM; TSXV: IOM), a provider of intraoperative neuromonitoring services (“IONM”), announced an annual, quarterly and monthly record for managed cases in the full-year period, the fourth quarter and the month of December 2021. John A. Farlinger, executive chairman and CEO said, “The Company reported our highest number of managed cases in the full-year period, the fourth quarter and the month of December 2021. In 2021, Assure performed approximately 17,400 managed cases, exceeding our full-year forecast. This total included more than 5,000 managed cases in the fourth quarter of 2021 and over 1,900 in the month of December. Comparatively, in 2020, we performed over 9,900 managed cases during the full year, including more than 3,000...

Data to be presented suggests ACER-001 could represent a potential alternative to sodium and glycerol phenylbutyrate for treatment of UCDs NEWTON, Mass. and GENEVA, Jan. 27, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced the acceptance of four ACER-001 abstracts for poster presentations at the upcoming Society for Inherited Metabolic Disorders (SIMD) Annual Meeting on April 10-13, 2022 in Orlando, Florida, and the Genetic Metabolic Dieticians International (GMDI) Conference on May 4-7, 2022, in Las Vegas, Nevada. The ACER-001 New Drug Application (NDA) for urea cycle disorders (UCDs) is currently under U.S. Food and Drug Administration (FDA) review with a Prescription Drug User Fee Act (PDUFA)...

McKeon Has Over 15 Years of Experience in Brand Marketing and is One of Vital Farms’ Most Tenured Marketing Leaders AUSTIN, Texas, Jan. 27, 2022 (GLOBE NEWSWIRE) — Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today announced the appointment of Kathryn McKeon to Chief Marketing Officer (CMO) effective January 27, 2022. McKeon has over 15 years of experience in brand marketing, with a specific focus on building global and emerging consumer food brands. As CMO, McKeon will oversee the Brand, Content, Community Management, Shopper Marketing, Consumer Insights, Communications and Creative Design marketing functions. McKeon joined Vital Farms in 2016 as one of the first marketing leaders. In her more than five years with the company, she has served in several marketing...

NORTH BILLERICA, Mass., Jan. 27, 2022 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) announced that its subsidiary, EXINI Diagnostics AB (EXINI), has entered into a collaboration with the Prostate Cancer Clinical Trials Consortium (PCCTC) to advance artificial intelligence (AI)-enabled imaging biomarkers in prostate cancer. The PCCTC is a premier multicenter clinical research organization specializing in cutting-edge prostate cancer research recognized for its culture of transparent project co-development between investigators, research sites and industry partners. The group’s distinguished investigators work together on a single mission: to design, implement and complete hypothesis-driven trials in prostate cancer, translating scientific discoveries into improved standards of care. Lantheus’ prostate cancer...

-MeiraGTx Receives $30 Million Cash Milestone Payment -MeiraGTx, in Collaboration with Janssen Pharmaceuticals, Inc., is Now Dosing Patients in the Phase 3 Lumeos Clinical Trial in X-linked Retinitis Pigmentosa -MeiraGTx Remains Eligible for Further Development and Commercial Milestones Related to botaretigene sparoparvovec (AAV-RPGR), as well as for AAV-CNGB3 and AAV-CNGA3 LONDON and NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has received a $30 million payment from Janssen Pharmaceuticals, Inc. (Janssen), part of the Janssen Pharmaceutical Companies of Johnson & Johnson, for a clinical milestone in the Phase 3 Lumeos trial of botaretigene sparoparvovec (AAV-RPGR), an investigational gene therapy for the...

TORONTO, Jan. 27, 2022 (GLOBE NEWSWIRE) — Celestica Inc. (NYSE, TSX: CLS), a leader in design, manufacturing and supply chain solutions for the world’s most innovative companies, today announced that the Annual Meeting of its Shareholders will be held on Thursday, April 28, 2022 at 9:30 a.m. EDT in a virtual format due to the ongoing public health concerns related to the COVID-19 pandemic. Celestica also announced that it has set Friday, March 11, 2022 as the record date for determining shareholders of the company who are entitled to receive notice of, and to vote at, the meeting. This year, Celestica will be using the notice-and-access method for delivering the company’s proxy statement and related materials to shareholders eligible to participate at the meeting. Shareholders should expect to receive a notice-and-access...

NEW YORK and CHICAGO, Jan. 27, 2022 (GLOBE NEWSWIRE) — ESPN Enterprises, Inc. (“ESPN”) and Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced a multi-year renewal of its relationship that builds upon the digital integrations powering the partnership, with a significant focus on linear and addressable media. As the Official Ticketing Partner of ESPN, Vivid Seats will continue to provide ESPN users and sports fans across the country with easy access to one of the deepest and broadest selections of tickets for sporting events. Since 2017, ESPN and Vivid Seats have worked together to integrate a seamless ticket-buying experience from Vivid Seats throughout...